The landscape of dementia prognosis has developed drastically with the advent of advanced biomarkers, including amyloid PET scans, tau imaging, and blood-centered assessments that may detect Alzheimer's pathology years in advance of indicators emerge. When these technological developments represent amazing progress in being familiar with neurodegenerative conditions, they have not https://epelis875xjt6.wikipublicist.com/user